Gulf Breeze, FLNCT07010471Now EnrollingIRB Ready

Developmental and Epileptic Encephalopathy 1 Clinical Trial in Gulf Breeze, FL

Access cutting-edge developmental and epileptic encephalopathy 1 treatment through this clinical trial at a research site in Gulf Breeze. Study-provided care at no cost to qualified participants.

Sponsored by Praxis Precision Medicines

Quick Self-Assessment

See if you qualify for this Gulf Breeze location

Preparing your pre-screening questions…

Expert Care in Gulf Breeze

Access developmental and epileptic encephalopathy 1 specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related developmental and epileptic encephalopathy 1 treatment provided free

Apply for This Gulf Breeze Location

Check if you qualify for this developmental and epileptic encephalopathy 1 clinical trial in Gulf Breeze, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Gulf Breeze

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Gulf Breeze site if eligible
  4. 4Begin participation

About This Developmental and Epileptic Encephalopathy 1 Study in Gulf Breeze

A Phase 3, Randomized, Multi-Center, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Relutrigine in Participants with Developmental and Epileptic Encephalopathies Followed by an Open-Label Extension

Sponsor: Praxis Precision Medicines

Who Can Participate

Inclusion Criteria

Has a documented diagnosis of a developmental and epileptic encephalopathy.
Onset of seizures \<12 years old.
Has a weight \>7 kg at the time of signing consent/assent.

Exclusion Criteria

Has a history of left bundle branch block, arrhythmias, Brugada syndrome, congenital heart disease, familial short QT syndrome, or family history of sudden death or ventricular arrhythmias, including idiopathic ventricular fibrillation.
Had 2 or more episodes of convulsive status epilepticus requiring hospitalization and intubation in the 6 months prior to Screening.
Has an abnormal ECG reading, including a QT interval corrected for heart rate using Bazett's method (QTcB) \<350 and \>450 ms (males), or \<360 and \>460 ms (females) at Screening and/or on Day 1.
Any nerve stimulation must have been placed at least 3 months prior to Screening with at least 1 month of stable settings prior to Screening.
Has received any other experimental or investigational drug, device, or other therapy within 30 days or 5 half-lives (whichever is longer) prior to Screening, including any prior use of gene therapy.
Is currently pregnant or breastfeeding or is planning to become pregnant during the clinical trial or within 5 half-lives of the last study drug dose.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Gulf Breeze?

Yes, this clinical trial (NCT07010471) has an active research site in Gulf Breeze, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Developmental and Epileptic Encephalopathy 1 Treatment Options in Gulf Breeze, FL

If you're searching for developmental and epileptic encephalopathy 1 treatment options in Gulf Breeze, FL, this clinical trial (NCT07010471) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Gulf Breeze research site is actively enrolling participants for this clinical trial. You'll receive care from experienced developmental and epileptic encephalopathy 1 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all developmental and epileptic encephalopathy 1 clinical trials near you to find additional studies recruiting in your area.

More Epilepsy Trials in Gulf Breeze, FL

See all epilepsy clinical trials recruiting in Gulf Breeze — not just this study.

Browse Epilepsy Trials in Gulf Breeze →

Browse More Trials by Condition

Epilepsy TrialsPulmonary Hypertension TrialsInterstitial Cystitis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Gulf Breeze?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Gulf Breeze, FL